De beoordeling van nieuwe geneesmiddelen. Article in Pharmaceutisch weekblad 3(1) Henk Buurma at Independent Researcher. Henk Buurma. Buy Het juiste medicijn: ruim geneesmiddelen kritisch beoordeeld 01 by Marcel Bouvy, Henk Buurma (ISBN: ) from Amazon’s Book Store. Buurma, H., Jong-van den Berg, L.T.W. de, Leufkens, H.G.M., Het geneesmiddel, Wetenschappelijke uitgeverij Bunge, Utrecht Callon, M, Law, J., Rip, A.

Author: Vudobar Goltihn
Country: Saudi Arabia
Language: English (Spanish)
Genre: Technology
Published (Last): 27 June 2018
Pages: 456
PDF File Size: 4.58 Mb
ePub File Size: 10.14 Mb
ISBN: 111-4-21400-987-4
Downloads: 51518
Price: Free* [*Free Regsitration Required]
Uploader: Kazrazshura

Elsevier Gezondheidszorgp. Construct and concurrent validity of a patient-reported adverse drug event questionnaire: Physician, organizational, and patient factors associated geneeamiddel suboptimal blood pressure mManagement in Type 2 diabetic patients in primary care Schaars, C. New renal guidelines; is more better? Bet of bioethical inquiry. Relationship between guideline treatment and health-related quality of life in asthma Pont, L. Primary prevention of major cardiovascular and cerebrovascular events with statins in diabetic patients: Pharmacy-based predictors of non-persistence with and non-adherence to statin treatment among patients on oral diabetes medication in the Netherlands Alfian, S.


Identifying distinct subgroups Sidorenkov, G.

Petra Denig – Research database – University of Groningen

Journal of Clinical Pharmacy and Therapeutics. International Journal of Clinical Pharmacy. The LifeLines cohort de Vries, J.

Nederlands Tijdschrift voor Geneeskunde. Trajectories of long-term exposure to anticholinergic and sedative drugs: Do we need individualised prescribing quality assessment? Perceived barriers for treatment of chronic heart failure in general practice; are they affecting performance?

Journal of Internal Medicine. Scope and nature of prescribing decisions made by general practitioners Denig, P. Reasons of general practitioners for not prescribing lipid-lowering medication to patients with diabetes: Geneesmkddel decision-making by prescribers Denig, P.

There was a problem providing the content you requested

Voorschrijven van geneesmiddelen Denig, P. Pharmcoepidemiology and Drug Safety. Quality of Life Research. Does comorbidity explain trends in prescribing of newer antihypertensive agents? University of Groningen staff: About us How to find us prof. Identification of major cardiovascular events in patients with diabetes using primary care data Pouwels, K.

prof. dr. P. (Petra) Denig

Willen artsen wel transmurale richtlijnen? Validity of performance indicators for assessing prescribing quality: Uptake of angiotensin II receptor blockers in the treatment of hypertension Greving, J.


Clinical relevance of the gap between pre-marketing trials and medical practice: Exploring differences in adherence to guidelines between three European countries Veninga, C.

Determinants for the adoption of angiotensin II receptor blockers by general practitioners Greving, J. British Journal of Clinical Pharmacology. Predictors of HbA1c levels in patients initiating metformin Martono, D. Physician, organizational, and patient factors associated with suboptimal blood pressure management in type 2 diabetic patients in primary care Schaars, C. The case of diabetes treatment Denig, P.

A pilot qualitative study to explore stakeholder opinions regarding prescribing quality indicators Martirosyan, L.

Voorschrijven van geneesmiddelen Haaijer-Ruskamp, F. Succes- en faalfactoren voor implementatie in de praktijk Denig, P. Differential effects of comorbidity on antihypertensive and glucose-regulating treatment in diabetes mellitus: